Evidence map›Paper›PMID 33057385›Full record

ArticlePloS one2020

Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American children.

Juan C Lopez-Alvarenga, Geetha Chittoor, Solomon F D Paul, Sobha Puppala, Vidya S Farook, Sharon P Fowler, Roy G Resendez, Joselin Hernandez-Ruiz, Alvaro Diaz-Badillo, David Salazar and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Acanthosis Nigricans: Pointer of Endocrine Entities.Diagnostics (Basel, Switzerland) · 2022
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Juan C Lopez-AlvarengaDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.ORCID 0000-0002-0966-8766
Geetha ChittoorBiomedical and Translational Informatics, Geisinger Health System, Danville, PA, United States of America.
Solomon F D PaulDepartment of Human Genetics, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu, India.
Sobha PuppalaDepartment of Internal Medicine, Wake Forest University, Winston-Salem, NC, United States of America.
Vidya S FarookDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Sharon P FowlerDepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX, United States of America.ORCID 0000-0003-1117-683X
Roy G ResendezDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Joselin Hernandez-RuizDepartment of Pharmacology, Hospital General de Mexico "Dr. Eduardo Liceaga", Mexico City, Mexico.
Alvaro Diaz-BadilloDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
David SalazarBorder Health Office, College of Health Professions, University of Texas Rio Grande Valley, Edinburg, TX, United States of America.
Doreen D GarzaBorder Health Office, College of Health Professions, University of Texas Rio Grande Valley, Edinburg, TX, United States of America.
Donna M LehmanDepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX, United States of America.
Srinivas MummidiDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Rector AryaDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Christopher P JenkinsonDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Jane L LynchDepartment of Pediatrics, University of Texas Health San Antonio, San Antonio, TX, United States of America.
Ralph A DeFronzoDepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX, United States of America.
John BlangeroDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
Daniel E HalePediatric Endocrinology and Diabetes, Penn State University, Hershey, PA, United States of America.
Ravindranath DuggiralaDepartment of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Edinburg and Brownsville, TX, United States of America.
The University of Texas Rio Grande Valley · USThe University of Texas Health Science Center at San Antonio · USGeisinger Health System · USHospital General de México · MXPenn State Milton S. Hershey Medical Center · USSri Ramachandra Institute of Higher Education and Research · INWake Forest University · US

Funding

PEDIGREE ANALYSIS OF LIPOPROTEIN PHENOTYPESP01HL045522 · NHLBI · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI ALMASY, LAURA A. · 1991 to 2012
$27.6M
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERSM01RR001346 · NCRR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ESCAMILLA, MICHAEL A · 1985 to 2008
$23.1M
Quantitative Trait Locus Mapping in Human PedigreesR37MH059490 · NIMH · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI BLANGERO, JOHN · 2001 to 2010
$6.8M
NIDDM SUSCEPTIBILITY GENES IN MEXICAN-AMERICANSR01DK047482 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEHMAN, DONNA M · 1993 to 2010
$5.4M
SOLAR-Eclipse Computational Tools for Imaging GeneticsR01EB015611 · NIBIB · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOCHUNOV, PETER V. · 2012 to 2024
$5.0M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR017515 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 2003 to 2003
$3.1M
The Metabolic Syndrome in Mexican American ChildrenR01HD049051 · NICHD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI DUGGIRALA, RAVINDRANATH · 2005 to 2009
$2.4M
GENETICS OF GALLBLADDER DISEASE IN MEXICAN AMERICANSR01DK053889 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DUGGIRALA, RAVINDRANATH · 1998 to 2011
$2.3M
High Performance Computing System for Human GenomicsS10RR029392 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI BLANGERO, JOHN · 2010 to 2010
$2.1M
Genetics of Birth Weight in Mexican AmericansR01HD041111 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DUGGIRALA, RAVINDRANATH · 2001 to 2005
$1.9M
Type 2 Diabetes Gene Discovery Linked to 3p in HispanicsR01DK070746 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEHMAN, DONNA M · 2007 to 2009
$1.4M
Early Life and genetic effects on obesity and diabetesK01DK064867 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI HUNT, KELLY J · 2003 to 2006
$510k
NCRR NIH HHS C06 RR013556NCRR NIH HHS C06 RR017515NCRR NIH HHS M01 RR001346NCRR NIH HHS S10 RR029392NHLBI NIH HHS P01 HL045522NIBIB NIH HHS R01 EB015611NICHD NIH HHS R01 HD041111NICHD NIH HHS R01 HD049051NIDDK NIH HHS K01 DK064867NIDDK NIH HHS R01 DK047482NIDDK NIH HHS R01 DK053889NIDDK NIH HHS R01 DK070746NIMH NIH HHS R01 MH059490NIMH NIH HHS R37 MH059490
6 · The paper itself

Abstract

aimAcanthosis nigricans (AN) is a strong correlate of obesity and is considered a marker of insulin resistance (IR). AN is associated with various other cardiometabolic risk factors (CMRFs). However, the direct causal relationship of IR with AN in obesity has been debated. Therefore, we aimed to examine the complex causal relationships among the troika of AN, obesity, and IR in Mexican Americans (MAs).

methodsWe used data from 670 non-diabetic MA children, aged 6-17 years (49% girls). AN (prevalence 33%) severity scores (range 0-5) were used as a quasi-quantitative trait (AN-q) for analysis. We used the program SOLAR for determining phenotypic, genetic, and environmental correlations between AN-q and CMRFs (e.g., BMI, HOMA-IR, lipids, blood pressure, hs-C-reactive protein (CRP), and Harvard physical fitness score (PFS)). The genetic and environmental correlations were subsequently used in mediation analysis (AMOS program). Model comparisons were made using goodness-of-fit indexes.

resultsHeritability of AN-q was 0.75 (p<0.0001). It was positively/significantly (p<0.05) correlated with traits such as BMI, HOMA-IR, and CRP, and negatively with HDL-C and PFS. Of the models tested, indirect mediation analysis of BMI→HOMA-IR→AN-q yielded lower goodness-of-fit than a partial mediation model where BMI explained the relationship with both HOMA-IR and AN-q simultaneously. Using complex models, BMI was associated with AN-q and IR mediating most of the CMRFs; but no relationship between IR and AN-q.

conclusionOur study suggests that obesity explains the association of IR with AN, but no causal relationship between IR and AN in Mexican American children.

Indexed as

Insulin ResistanceAcanthosis NigricansAdolescentBiomarkersCardiovascular DiseasesChildFemaleHumansIncidenceMaleMetabolic SyndromeMexican AmericansObesityUnited StatesBiomarkers

Identifiers

PMID33057385
PMCPMC7561152
OpenAlexW3092828784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.